Hepion Pharmaceuticals, Inc. - HEPA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2025 · Q4 2024
Value (USD)
Total reported value ($000)
$6K
QoQ value delta ($000)
-$114K (-95.0%)
Implied price effect (QoQ)
-24.5%
Shares
Total shares
17,680
QoQ shares delta
-249,305 (-93.38%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (HEPA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2025)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 6 15,581 0.0%
BANK OF AMERICA CORP /DE/ 0 2 0.0%
FMR LLC 0 100 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 0 156 0.0%
MORGAN STANLEY 0 30 0.0%
GROUP ONE TRADING LLC 0 4 0.0%
Tower Research Capital LLC (TRC) 0 110 0.0%
Allworth Financial LP 0 1 0.0%
UBS Group AG 0 1 0.0%
OSAIC HOLDINGS, INC. 0 2 0.0%
SBI Securities Co., Ltd. 0 32 0.0%
BlackRock, Inc. 0 1,658 0.0%
Federation des caisses Desjardins du Quebec 0 3 0.0%